We are delighted to announce the appointment of Russell Wheatcroft as Chief Operating Officer of PHARMExcel. Russell’s appointment marks another significant step towards achieving PHARMExcel’s ambitious growth strategy to become the Clinical Research Organisation (CRO) of choice for UK and European academic trials, whilst continuing to expand its strategic commercial partnerships with growing biotech/pharma organisations.
With over 30 years commercial and operational experience across multiple sectors including Life Sciences and Healthcare, Russell brings considerable expertise and a strong track record in delivering highly regulated solutions to the pharma, biotech and healthcare sectors with a global focus.
Russell Wheatcroft commented about his recent appointment. “I’m very excited to be joining PHARMExcel and am looking forward to building on the strong relationships the team already have with our customers whilst enabling the company to bring its market leading solutions to new customers and territories”.
Yvanne Enever, CEO and Founder at PHARMExcel said “I’m thrilled that Russell is joining our executive leadership team at such an important time. PHARMExcel has an impressive reputation built on specialism and expertise. With Russell’s extensive knowledge of pharma products, services and consultancy-based solutions, he’ll be instrumental in enabling PHARMExcel to further enhance its market leading solutions to healthcare providers including the NHS and global private/public companies”.
PHARMExcel is an award-winning, full-service Contract Research Organisation (CRO) providing a flexible and innovative approach to clinical trial delivery. The company is recognised for its in-depth knowledge and experience of the clinical research environment, particularly in the UK, and has a network of regulatory and industry associates, allowing it to provide a global reach.
Media Contact
Katie Howe, Head of Marketing
E: katie.howe@pharmexcel-cro.com
T: +44 (0)20 3642 6654
